Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 11.7.20221 Min. Lesezeit
Determination of Regulatory Review Period for Purposes of Patent Extension; TABRECTA
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for TABRECTA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →